cataflam 1.5% oral drops solution
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - diclofenac sodium - oral drops solution - 1.5% - diclofenac sodium (0015307796) 15mg - diclofenac
desferal 500mg/vial powder for injection
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - deferoxamine mesilate - powder for injection - 500mg/vial - deferoxamine mesilate (0000138147) 500mg - deferoxamine
desferal 2g/vial powder for injection
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - deferoxamine mesilate - powder for injection - 2g/vial - deferoxamine mesilate (0000138147) 2g - deferoxamine
oculotect eye 1000iu/g gel
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - retinol palmitate - gel - 1000iu/g - retinol palmitate (0000079812) 10mg - retinol
ultracortenol 0.5% eye ointment
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - prednisolone pivalate - eye ointment - 0.5% - prednisolone pivalate (0001107999) 5mg - prednisolone
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - (αιμοσυγκολλητίνη και νευραμινιδάση) του στελέχους Α / Βιετνάμ / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - Εμβόλια - Ενεργός ανοσοποίηση έναντι του υποτύπου h5n1 του ιού της γρίπης Α. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 και 5. 1 για διαθέσιμα δεδομένα σχετικά με διαφορετικούς συνδυασμούς).
timolol/novartis 0.25% w/v ey.dro.sol
novartis (hellas) a.e.b.e. - timolol - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0.25% w/v - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
timolol/novartis 0.5% w/v ey.dro.sol
novartis (hellas) a.e.b.e. - timolol - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0.5% w/v - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
enviage
novartis europharm ltd. - αλισκιρένη - Υπέρταση - Παράγοντες που δρουν στο σύστημα ρενίνης-αγγειοτενσίνης - Θεραπεία της ιδιοπαθούς υπέρτασης.